Cardiovascular burden and percutaneous interventions in Russian Federation: systematic epidemiological update
1De Haar Research Foundation, Rotterdam, The Netherlands, New York, NY, USA.
Cardiovascular Diagnosis and Therapy
|February 7, 2017
Summary
Cardiovascular diseases cause over half of all deaths in Russia, with high mortality rates and shorter lifespans. Addressing major risk factors like smoking, alcohol, and unhealthy diets is crucial for public health.
Area of Science:
- Epidemiology
- Public Health
- Cardiology
Background:
- High cardiovascular (CV) mortality and shorter lifespans in Russia compared to Western societies.
- Absence of established monitoring or screening systems for major CV risk factors.
- CV diseases account for a significant portion of all deaths in Russia.
Purpose of the Study:
- To conduct a systematic epidemiological update on the CV burden in Russia.
- To explore trends in CV burden across all 83 regions of Russia.
- To identify major modifiable risk factors contributing to CV diseases.
Main Methods:
- Systematic epidemiological review of national mass screenings, randomized clinical trials, and statistical datasets.
- Analysis of Russian-speaking national data sources from 2001-2014.
- Inclusion of the NANOM-FIM trial (NCT01270139) as a real-world population study.
Main Results:
- Cardiovascular diseases accounted for 54.9% of all deaths (2011-2014).
- Major modifiable risk factors include smoking, excessive alcohol consumption, unhealthy diet, psychosocial factors, and physical inactivity.
- High prevalence of dyslipidemia (86.7%), obesity (16.7%), and hypertension (40.8% to 86.1%) observed.
Conclusions:
- Despite a documented 27% 10-year decline in CV mortality, the CV burden in Russia remains high.
- New national programs and aggressive efforts are required to tackle CV diseases.
- Mortality statistics highlight the urgent need for interventions to reduce CV disease impact.
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
357
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
357
Coronary Artery Disease IV: Preventive Measures
789
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
789
Peripheral Artery Disease III: Interprofessional Care
469
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
469
Coronary Artery Disease I: Introduction
1.4K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.4K
Atherosclerosis III: Management
540
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
540
Cardiac Catheterization I: Pre-Procedure Overview
2.0K
Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
2.0K


